Compositions and methods for diagnosing lung cancers
US10782297B2 · kind B2 · utility
0Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 16, 2014 |
| Grant date | Sep 22, 2020 |
| Priority date | — |
| Expiry date | Apr 16, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/57423
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides diagnostics for identifying and distinguishing various types of lung cancers using serum and/or bronchioalveolar lavage fluid. Signatures of secretory proteins are used to identify and distinguish lung cancers. The biomarker signatures may also be used to separate lung cancers from other inflammatory diseases, monitor progression, or assess treatment efficacy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.